LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 27

Search options

  1. Article ; Online: Vasculopathy in COVID-19.

    Flaumenhaft, Robert / Enjyoji, Keiichi / Schmaier, Alec A

    Blood

    2022  Volume 140, Issue 3, Page(s) 222–235

    Abstract: COVID-19 is a primary respiratory illness that is frequently complicated by systemic involvement of the vasculature. Vascular involvement leads to an array of complications ranging from thrombosis to pulmonary edema secondary to loss of barrier function. ...

    Abstract COVID-19 is a primary respiratory illness that is frequently complicated by systemic involvement of the vasculature. Vascular involvement leads to an array of complications ranging from thrombosis to pulmonary edema secondary to loss of barrier function. This review will address the vasculopathy of COVID-19 with a focus on the role of the endothelium in orchestrating the systemic response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. The endothelial receptor systems and molecular pathways activated in the setting of COVID-19 and the consequences of these inflammatory and prothrombotic changes on endothelial cell function will be discussed. The sequelae of COVID-19 vascular involvement at the level of organ systems will also be addressed, with an emphasis on the pulmonary vasculature but with consideration of effects on other vascular beds. The dramatic changes in endothelial phenotypes associated with COVID-19 has enabled the identification of biomarkers that could help guide therapy and predict outcomes. Knowledge of vascular pathogenesis in COVID-19 has also informed therapeutic approaches that may control its systemic sequelae. Because our understanding of vascular response in COVID-19 continues to evolve, we will consider areas of controversy, such as the extent to which SARS-CoV-2 directly infects endothelium and the degree to which vascular responses to SARS-CoV-2 are unique or common to those of other viruses capable of causing severe respiratory disease. This conceptual framework describing how SARS-CoV-2 infection affects endothelial inflammation, prothrombotic transformation, and barrier dysfunction will provide a context for interpreting new information as it arises addressing the vascular complications of COVID-19.
    MeSH term(s) COVID-19/complications ; Humans ; Inflammation ; SARS-CoV-2 ; Thrombosis/etiology ; Vascular Diseases/etiology
    Language English
    Publishing date 2022-01-04
    Publishing country United States
    Document type Journal Article ; Review ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 80069-7
    ISSN 1528-0020 ; 0006-4971
    ISSN (online) 1528-0020
    ISSN 0006-4971
    DOI 10.1182/blood.2021012250
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Vascular Disease Patient Information Page: COVID-19-related thrombosis.

    Schmaier, Alec A / Schmaier, Alvin H

    Vascular medicine (London, England)

    2020  Volume 25, Issue 6, Page(s) 604–607

    MeSH term(s) Anticoagulants/therapeutic use ; Blood Coagulation/drug effects ; COVID-19/blood ; COVID-19/diagnosis ; COVID-19/drug therapy ; COVID-19/virology ; Host-Pathogen Interactions ; Humans ; Risk Factors ; SARS-CoV-2/pathogenicity ; Thrombosis/blood ; Thrombosis/diagnosis ; Thrombosis/prevention & control ; Thrombosis/virology
    Chemical Substances Anticoagulants
    Keywords covid19
    Language English
    Publishing date 2020-10-12
    Publishing country England
    Document type Journal Article ; Patient Education Handout
    ZDB-ID 1311628-9
    ISSN 1477-0377 ; 1358-863X
    ISSN (online) 1477-0377
    ISSN 1358-863X
    DOI 10.1177/1358863X20963804
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Venous Thromboembolism for the Practicing Cardiologist.

    Pribish, Abby M / Secemsky, Eric A / Schmaier, Alec A

    Cardiology clinics

    2021  Volume 39, Issue 4, Page(s) 551–566

    Abstract: Venous thromboembolism (VTE), encompassing pulmonary embolism (PE) and deep vein thrombosis (DVT), is encountered commonly. Acute PE may present as a high-risk cardiovascular emergency, and acute DVT can cause acute and chronic vascular complications. ... ...

    Abstract Venous thromboembolism (VTE), encompassing pulmonary embolism (PE) and deep vein thrombosis (DVT), is encountered commonly. Acute PE may present as a high-risk cardiovascular emergency, and acute DVT can cause acute and chronic vascular complications. The goal of this review is to ensure that cardiologists are comfortable managing VTE-including risk stratification, anticoagulation therapy, and familiarity with primary reperfusion therapy. Clinical assessment and determination of degree of right ventricular dysfunction are critical in initial risk stratification of PE and determination of parenteral versus oral anticoagulation therapy. Direct oral anticoagulants have emerged as preferred first-line oral anticoagulation strategy in VTE scenarios.
    MeSH term(s) Anticoagulants/therapeutic use ; Cardiologists ; Humans ; Pulmonary Embolism/diagnosis ; Pulmonary Embolism/epidemiology ; Pulmonary Embolism/therapy ; Venous Thromboembolism/epidemiology ; Venous Thromboembolism/etiology ; Venous Thrombosis
    Chemical Substances Anticoagulants
    Language English
    Publishing date 2021-10-22
    Publishing country Netherlands
    Document type Journal Article ; Review
    ZDB-ID 1196385-2
    ISSN 1558-2264 ; 0733-8651
    ISSN (online) 1558-2264
    ISSN 0733-8651
    DOI 10.1016/j.ccl.2021.06.008
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Vascular Disease Patient Information Page

    Schmaier, Alec A / Schmaier, Alvin H

    Vascular Medicine

    COVID–19-related thrombosis

    2020  , Page(s) 1358863X2096380

    Keywords Cardiology and Cardiovascular Medicine ; covid19
    Language English
    Publisher SAGE Publications
    Publishing country us
    Document type Article ; Online
    ZDB-ID 1311628-9
    ISSN 1477-0377 ; 1358-863X
    ISSN (online) 1477-0377
    ISSN 1358-863X
    DOI 10.1177/1358863x20963804
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  5. Article ; Online: Are Patients Getting Their Aspirin's Worth in Ischemic Stroke?

    Schmaier, Alec A / Bhatt, Deepak L

    Journal of the American Heart Association

    2018  Volume 7, Issue 11

    MeSH term(s) Aspirin ; Brain Ischemia ; Humans ; Platelet Aggregation Inhibitors ; Platelet Function Tests ; Stroke
    Chemical Substances Platelet Aggregation Inhibitors ; Aspirin (R16CO5Y76E)
    Language English
    Publishing date 2018-06-01
    Publishing country England
    Document type Editorial ; Comment
    ZDB-ID 2653953-6
    ISSN 2047-9980 ; 2047-9980
    ISSN (online) 2047-9980
    ISSN 2047-9980
    DOI 10.1161/JAHA.118.009564
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: A Lack of Reserve: Recognizing the Large Impact of Small Vessels in the Heart.

    Schmaier, Alec A / Taqueti, Viviany R

    Circulation

    2018  Volume 138, Issue 4, Page(s) 424–428

    MeSH term(s) Aged ; Angina Pectoris/diagnostic imaging ; Angina Pectoris/physiopathology ; Angina Pectoris/therapy ; Coronary Angiography ; Coronary Artery Disease/diagnostic imaging ; Coronary Artery Disease/physiopathology ; Coronary Artery Disease/therapy ; Coronary Restenosis/etiology ; Coronary Restenosis/physiopathology ; Coronary Stenosis/diagnostic imaging ; Coronary Stenosis/physiopathology ; Coronary Stenosis/therapy ; Coronary Vessels/diagnostic imaging ; Coronary Vessels/physiopathology ; Drug-Eluting Stents ; Electrocardiography ; Female ; Fractional Flow Reserve, Myocardial ; Humans ; Microcirculation ; Myocardial Perfusion Imaging/methods ; Percutaneous Coronary Intervention/adverse effects ; Percutaneous Coronary Intervention/instrumentation ; Positron-Emission Tomography ; Treatment Outcome
    Language English
    Publishing date 2018-07-23
    Publishing country United States
    Document type Case Reports ; Journal Article ; Research Support, N.I.H., Extramural
    ZDB-ID 80099-5
    ISSN 1524-4539 ; 0009-7322 ; 0069-4193 ; 0065-8499
    ISSN (online) 1524-4539
    ISSN 0009-7322 ; 0069-4193 ; 0065-8499
    DOI 10.1161/CIRCULATIONAHA.117.031602
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Venous Thromboembolism and Cancer.

    Schmaier, Alec A / Ambesh, Paurush / Campia, Umberto

    Current cardiology reports

    2018  Volume 20, Issue 10, Page(s) 89

    Abstract: Purpose of review: This review aims to summarize the epidemiology, current pathophysiologic understanding, and state-of-the-art treatment of venous thromboembolism (VTE) in cancer patients.: Recent findings: The risk of VTE varies among cancer ... ...

    Abstract Purpose of review: This review aims to summarize the epidemiology, current pathophysiologic understanding, and state-of-the-art treatment of venous thromboembolism (VTE) in cancer patients.
    Recent findings: The risk of VTE varies among cancer patients. Recently introduced prediction models better identify those at high risk of VTE. New mechanisms underlying hypercoagulability in cancer have been uncovered. Initial data on the efficacy of direct oral anticoagulants (DOACs) compared with low-molecular weight heparin to treat VTE in patients with cancer are promising. However, they may be associated with higher risk of gastrointestinal bleeding. VTE causes significant morbidity and mortality in cancer patients. Our understanding of the mechanisms of VTE, including those associated with cancer treatments, has significantly grown. The assessment of the benefit/risk balance of VTE treatment remains challenging in many patients with cancer. The introduction of DOACs has expanded treatment options, but knowledge on their efficacy and safety is incomplete.
    MeSH term(s) Administration, Oral ; Anticoagulants/administration & dosage ; Anticoagulants/adverse effects ; Blood Coagulation ; Hemorrhage/chemically induced ; Heparin, Low-Molecular-Weight/therapeutic use ; Humans ; Neoplasms/complications ; Neoplasms/mortality ; Recurrence ; Risk Assessment ; Risk Factors ; Venous Thromboembolism/etiology ; Venous Thromboembolism/prevention & control
    Chemical Substances Anticoagulants ; Heparin, Low-Molecular-Weight
    Language English
    Publishing date 2018-08-20
    Publishing country United States
    Document type Journal Article ; Review
    ZDB-ID 2055373-0
    ISSN 1534-3170 ; 1523-3782
    ISSN (online) 1534-3170
    ISSN 1523-3782
    DOI 10.1007/s11886-018-1034-3
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: TMEM16E regulates endothelial cell procoagulant activity and thrombosis.

    Schmaier, Alec A / Anderson, Papa F / Chen, Siyu M / El-Darzi, Emale / Aivasovsky, Ivan / Kaushik, Milan P / Sack, Kelsey D / Hartzell, H Criss / Parikh, Samir M / Flaumenhaft, Robert / Schulman, Sol

    The Journal of clinical investigation

    2023  Volume 133, Issue 11

    Abstract: Endothelial cells (ECs) normally form an anticoagulant surface under physiological conditions, but switch to support coagulation following pathogenic stimuli. This switch promotes thrombotic cardiovascular disease. To generate thrombin at physiologic ... ...

    Abstract Endothelial cells (ECs) normally form an anticoagulant surface under physiological conditions, but switch to support coagulation following pathogenic stimuli. This switch promotes thrombotic cardiovascular disease. To generate thrombin at physiologic rates, coagulation proteins assemble on a membrane containing anionic phospholipid, most notably phosphatidylserine (PS). PS can be rapidly externalized to the outer cell membrane leaflet by phospholipid "scramblases," such as TMEM16F. TMEM16F-dependent PS externalization is well characterized in platelets. In contrast, how ECs externalize phospholipids to support coagulation is not understood. We employed a focused genetic screen to evaluate the contribution of transmembrane phospholipid transport on EC procoagulant activity. We identified 2 TMEM16 family members, TMEM16F and its closest paralog, TMEM16E, which were both required to support coagulation on ECs via PS externalization. Applying an intravital laser-injury model of thrombosis, we observed, unexpectedly, that PS externalization was concentrated at the vessel wall, not on platelets. TMEM16E-null mice demonstrated reduced vessel-wall-dependent fibrin formation. The TMEM16 inhibitor benzbromarone prevented PS externalization and EC procoagulant activity and protected mice from thrombosis without increasing bleeding following tail transection. These findings indicate the activated endothelial surface is a source of procoagulant phospholipid contributing to thrombus formation. TMEM16 phospholipid scramblases may be a therapeutic target for thrombotic cardiovascular disease.
    MeSH term(s) Animals ; Mice ; Blood Platelets/metabolism ; Cardiovascular Diseases/metabolism ; Endothelial Cells/metabolism ; Mice, Knockout ; Phosphatidylserines ; Phospholipid Transfer Proteins/genetics ; Phospholipid Transfer Proteins/metabolism ; Phospholipids/metabolism ; Thrombosis/pathology
    Chemical Substances endothelial cell procoagulant activity ; Phosphatidylserines ; Phospholipid Transfer Proteins ; Phospholipids ; ANO5 protein, mouse
    Language English
    Publishing date 2023-06-01
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 3067-3
    ISSN 1558-8238 ; 0021-9738
    ISSN (online) 1558-8238
    ISSN 0021-9738
    DOI 10.1172/JCI163808
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Meningioma resection and venous thromboembolism incidence, management, and outcomes.

    Rizzo, Samantha M / Tavakol, Sherwin / Bi, Wenya Linda / Li, Siling / Secemsky, Eric A / Campia, Umberto / Piazza, Gregory / Goldhaber, Samuel Z / Schmaier, Alec A

    Research and practice in thrombosis and haemostasis

    2023  Volume 7, Issue 2, Page(s) 100121

    Abstract: Background: Meningioma resection is associated with the risk of venous thromboembolism (VTE).: Objectives: To determine the incidence and risk factors for VTE following meningioma resection and VTE outcomes based on the type and timing of ... ...

    Abstract Background: Meningioma resection is associated with the risk of venous thromboembolism (VTE).
    Objectives: To determine the incidence and risk factors for VTE following meningioma resection and VTE outcomes based on the type and timing of anticoagulation.
    Methods: From 2011 to 2019, 901 consecutive patients underwent meningioma resection. We retrospectively evaluated the postoperative incidence of VTE and bleeding. For VTE, we determined the treatment strategy and rate of VTE complications and bleeding.
    Results: Pharmacologic prophylaxis was administered to 665 (73.8%) patients. The cumulative incidence for total postoperative VTE was 8.7% (95% CI: 6.9%-10.6%), and for symptomatic VTE was 6.0% (95% CI: 4.6%-7.7%). A multivariable model identified the following independent predictors of symptomatic VTE: history of VTE, obesity, and lack of pharmacologic prophylaxis. Following postoperative VTE, 58 (74.3%) patients received therapeutic anticoagulation either initially (33.3%) or after a median delay of 23.5 days (41.0%). Symptomatic recurrent VTE occurred in 13 (16.6%) patients. Following VTE, the use of subtherapeutic anticoagulation was associated with a lower rate of total VTE extension than no anticoagulation (17.5% vs 42.9%, OR 0.28, 95% CI: 0.09-0.93). In total, 14 patients (1.6%) experienced clinically relevant bleeding: 4 received therapeutic anticoagulants, 8 received prophylactic anticoagulation, and 2 received no anticoagulation. Among patients with VTE, 4 (5.1%) experienced bleeding.
    Conclusion: Recognition of risk factors for VTE following meningioma resection may help improve approaches to thromboprophylaxis. The management of postoperative VTE is highly variable, but most VTE patients are ultimately treated with therapeutic anticoagulants.
    Language English
    Publishing date 2023-03-15
    Publishing country United States
    Document type Journal Article
    ISSN 2475-0379
    ISSN (online) 2475-0379
    DOI 10.1016/j.rpth.2023.100121
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top